Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Prospective observational study in patients with obstructive lung disease: NOVELTY design

Helen K. Reddel, Maria Gerhardsson de Verdier, Alvar Agustí, Gary Anderson, Richard Beasley, Elisabeth H. Bel, Christer Janson, Barry Make, Richard J. Martin, Ian Pavord, David Price, Christina Keen, Asparuh Gardev, Stephen Rennard, Alecka Sveréus, Aruna T. Bansal, Lance Brannman, Niklas Karlsson, Javier Nuevo, Fredrik Nyberg, Simon S. Young, Jørgen Vestbo
ERJ Open Research 2019 5: 00036-2018; DOI: 10.1183/23120541.00036-2018
Helen K. Reddel
1Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Gerhardsson de Verdier
2Respiratory TA, Global Medical Affairs, AstraZeneca, Mölndal, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alvar Agustí
3Respiratory Institute, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERES, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Anderson
4Lung Health Research Centre, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Beasley
5Medical Research Institute of New Zealand, Wellington, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richard Beasley
Elisabeth H. Bel
6Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christer Janson
7Dept of Medical Sciences, Uppsala University, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barry Make
8National Jewish Health and University of Colorado Denver, Denver, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Barry Make
Richard J. Martin
8National Jewish Health and University of Colorado Denver, Denver, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Pavord
9Nuffield Dept of Medicine, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Price
10Observational and Pragmatic Research Institute, Singapore and Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Price
Christina Keen
11Early Clinical Development IMED Biotech Unit, AstraZeneca, Mölndal, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Asparuh Gardev
12Global Medical Affairs, AstraZeneca, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Rennard
13Early Clinical Development, IMED Biotech Unit, AstraZeneca, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alecka Sveréus
2Respiratory TA, Global Medical Affairs, AstraZeneca, Mölndal, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aruna T. Bansal
14Acclarogen Ltd, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lance Brannman
15US Medical Affairs, AstraZeneca, Gaithersberg, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niklas Karlsson
16Patient Reported Outcomes, Medical Evidence and Observational Research, Global Medical Affairs, AstraZeneca, Mölndal, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Nuevo
17Respiratory TA, Global Medical Affairs, AstraZeneca, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fredrik Nyberg
18Medical Evidence and Observational Research, Global Medical Affairs, AstraZeneca, Mölndal, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon S. Young
19Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jørgen Vestbo
20School of Biological Sciences, University of Manchester, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 5 no. 1
DOI 
https://doi.org/10.1183/23120541.00036-2018
PubMed 
30723727

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received March 3, 2018
  • Accepted November 13, 2018
  • Published online February 1, 2019.

Copyright & Usage 
Copyright ©ERS 2019 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Helen K. Reddel1,
  2. Maria Gerhardsson de Verdier2,
  3. Alvar Agustí3,
  4. Gary Anderson4,
  5. Richard Beasley5,
  6. Elisabeth H. Bel6,
  7. Christer Janson7,
  8. Barry Make8,
  9. Richard J. Martin8,
  10. Ian Pavord9,
  11. David Price10,
  12. Christina Keen11,
  13. Asparuh Gardev12,
  14. Stephen Rennard13,
  15. Alecka Sveréus2,
  16. Aruna T. Bansal14,
  17. Lance Brannman15,
  18. Niklas Karlsson16,
  19. Javier Nuevo17,
  20. Fredrik Nyberg18,
  21. Simon S. Young19 and
  22. Jørgen Vestbo20
  1. 1Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia
  2. 2Respiratory TA, Global Medical Affairs, AstraZeneca, Mölndal, Sweden
  3. 3Respiratory Institute, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERES, Barcelona, Spain
  4. 4Lung Health Research Centre, University of Melbourne, Melbourne, Australia
  5. 5Medical Research Institute of New Zealand, Wellington, New Zealand
  6. 6Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
  7. 7Dept of Medical Sciences, Uppsala University, Uppsala, Sweden
  8. 8National Jewish Health and University of Colorado Denver, Denver, CO, USA
  9. 9Nuffield Dept of Medicine, University of Oxford, Oxford, UK
  10. 10Observational and Pragmatic Research Institute, Singapore and Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK
  11. 11Early Clinical Development IMED Biotech Unit, AstraZeneca, Mölndal, Sweden
  12. 12Global Medical Affairs, AstraZeneca, Cambridge, UK
  13. 13Early Clinical Development, IMED Biotech Unit, AstraZeneca, Cambridge, UK
  14. 14Acclarogen Ltd, Cambridge, UK
  15. 15US Medical Affairs, AstraZeneca, Gaithersberg, MD, USA
  16. 16Patient Reported Outcomes, Medical Evidence and Observational Research, Global Medical Affairs, AstraZeneca, Mölndal, Sweden
  17. 17Respiratory TA, Global Medical Affairs, AstraZeneca, Madrid, Spain
  18. 18Medical Evidence and Observational Research, Global Medical Affairs, AstraZeneca, Mölndal, Sweden
  19. 19Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, UK
  20. 20School of Biological Sciences, University of Manchester, Manchester, UK
  1. Helen K. Reddel, Woolcock Institute of Medical Research, 431 Glebe Point Road, Glebe, NSW 2037, Australia. E-mail: Helen.reddel{at}sydney.edu.au
View Full Text

Funding

  • National Institute for Health Research

  • AstraZeneca

Article usage

Article usage: January 2019 to January 2023

AbstractFullPdf
Jan 2019011
Feb 201923944259
Mar 20191140360
Apr 20192242076
May 20191434238
Jun 20191434833
Jul 2019845224
Aug 2019472025
Sep 2019467833
Oct 2019168947
Nov 2019243436
Dec 2019630324
Jan 2020916538
Feb 2020210425
Mar 2020320225
Apr 2020610823
May 2020326822
Jun 2020312739
Jul 2020210651
Aug 2020510121
Sep 2020333353
Oct 2020813552
Nov 2020911849
Dec 202037533
Jan 202107243
Feb 202109756
Mar 202159754
Apr 202145847
May 202128040
Jun 202108153
Jul 202127439
Aug 202125729
Sep 2021199027
Oct 2021107741
Nov 2021137241
Dec 202105421
Jan 202226019
Feb 202234722
Mar 202244341
Apr 202233220
May 202214436
Jun 202236226
Jul 202225020
Aug 202296837
Sep 202207340
Oct 202215222
Nov 202245824
Dec 202203021
Jan 202364118

Altmetrics

PreviousNext
Back to top
Vol 5 Issue 1 Table of Contents
ERJ Open Research: 5 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prospective observational study in patients with obstructive lung disease: NOVELTY design
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Prospective observational study in patients with obstructive lung disease: NOVELTY design
Helen K. Reddel, Maria Gerhardsson de Verdier, Alvar Agustí, Gary Anderson, Richard Beasley, Elisabeth H. Bel, Christer Janson, Barry Make, Richard J. Martin, Ian Pavord, David Price, Christina Keen, Asparuh Gardev, Stephen Rennard, Alecka Sveréus, Aruna T. Bansal, Lance Brannman, Niklas Karlsson, Javier Nuevo, Fredrik Nyberg, Simon S. Young, Jørgen Vestbo
ERJ Open Research Feb 2019, 5 (1) 00036-2018; DOI: 10.1183/23120541.00036-2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prospective observational study in patients with obstructive lung disease: NOVELTY design
Helen K. Reddel, Maria Gerhardsson de Verdier, Alvar Agustí, Gary Anderson, Richard Beasley, Elisabeth H. Bel, Christer Janson, Barry Make, Richard J. Martin, Ian Pavord, David Price, Christina Keen, Asparuh Gardev, Stephen Rennard, Alecka Sveréus, Aruna T. Bansal, Lance Brannman, Niklas Karlsson, Javier Nuevo, Fredrik Nyberg, Simon S. Young, Jørgen Vestbo
ERJ Open Research Feb 2019, 5 (1) 00036-2018; DOI: 10.1183/23120541.00036-2018
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Discussion
    • Supplementary material
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Asthma and allergy
  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • The national chronic obstructive pulmonary disease screening program in China: rationale and design
  • Functional imaging in asthma and COPD: design of the NOVELTY ADPro substudy
  • Real-life effectiveness of indacaterol/glycopyrronium/mometasone for symptomatic relief of cough after switching from ICS/LABA therapy in patients with asthma: REACH study design
Show more Study protocol

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society